Sign in
WithdrawnNo phase

Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function

Key facts

Who runs it
Chinese University of Hong Kong
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Withdrawn
Started
1 Nov 2021
Ended
30 Nov 2023
Type of study
Interventional
Treatments tested
  • Lifestyle modification program
Record updated
20 February 2024
Why it stopped
no funding

Who can take part

Age
40 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 18 criteriaShow less

Who can take part

  • BMI ≥ 25kg/m2
  • impaired glucose tolerance which defined as plasma glucose at the range of 7.8 and 11 mmol/l 2 hours after 75g oral glucose solution intake,
  • willing to participate in lifestyle modification program
  • and capable of using continuous glucose monitoring (CGM) as judged by investigator

Who cannot take part

  • current participation in other weight loss or lifestyle interventions, or use of weight loss drugs,
  • current use of steroids
  • known obstructive sleep apnea on continuous positive airway pressure therapy
  • unstable cardiovascular disease (e.g. recent unstable angina or myocardial infarction within the previous 6 months or severe left ventricular failure; neuromuscular disease affecting or potentially affecting respiratory muscles; moderate to severe respiratory disease (i.e. breathlessness affecting activities of daily living) or documented hypoxemia or awake SaO2 <92%)
  • Use of psychoactive medication
  • allergy to medical grade adhesives
  • uncontrolled hypertension (blood pressure >140/90mmHg) or requiring more than two anti-hypertensive medication
  • history of stroke or brain injury,
  • psychiatric disease that limits the ability to give informed consent or complete the study
  • known diabetes, current or previous use of glucose lowering drug
  • Lactating or pregnant,
  • uncontrolled thyrotoxicosis
  • symptoms of cognitive deterioration (according to the Hong Kong Montreal Cognitive Assessment (HK-MoCA) at the score of <21)
  • predominant central sleep apnea

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Obstructive sleep apnea (OSA) may contribute to altered cognitive function in patients suffering from severe OSA. And lifestyle modification program may improve the cognitive function after 6 months of therapy.

The group in the trial

  • Lifestyle modification programOther group

    Patients with obstructive sleep apnea and prediabetes will have lifestyle modification program for 12 months

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Obstructive Sleep Apnea on Glucose Control and Cognitive Function - a Substudy of 'Continuous Glucose Monitoring as an Adjunct to Lifestyle Modification in Individuals With Impaired Glucose Tolerance: a Randomised Controlled Trial'
Record updated
20 February 2024